By Helgi Library - August 11, 2020
McKesson Europe made a net profit of EUR -14.5 mil with revenues of EUR 5,222 mil in 1Q2019, up by 80.3% and up by 0.412%...
By Helgi Library - August 11, 2020
McKesson Europe generated sales of EUR 5,222 mil in 1Q2019, up 0.412% compared to the previous year. Historically, between ...
By Helgi Library - October 12, 2020
McKesson Europe's total assets reached EUR 7,091 mil at the end of 1Q2019, up 2.79% compared to the previous year. ...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Valuation |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - August 11, 2020
McKesson Europe's operating cash flow stood at EUR 77.4 mil in 1Q2019, up 39.6% when compared to the previous year. Historically, between 1Q2001 - 1Q2019, the firm’s operating cash flow reached a high of EUR 402 mil in 2Q2007 and a low of EUR -266 mil ...
By Helgi Library - August 11, 2020
McKesson Europe made a net profit of EUR -59.0 mil with revenues of EUR 21,177 mil in 2018, up by 80.3% and up by 0.412%, respectively, compared to the previous year. This translates into a net margin of -0.279%. Historically, between 1993 - 2018, ...
By Helgi Library - August 11, 2020
McKesson Europe stock traded at EUR 25.2 per share at the end 2018 translating into a market capitalization of USD 6,714 mil. Since the end of 2013, stock has appreciated by 30.8% representing an annual average growth of 5.52%. In absolute terms, the va...
By Helgi Library - August 11, 2020
McKesson Europe employed 24,878 employees in 2018, down 3.32% compared to the previous year. Historically, between 1993 and 2018, the firm's workforce hit a high of 46,977 employees in 2010 and a low of 11,313 employees in 1993. Average personnel cos...
By Helgi Library - August 11, 2020
McKesson Europe stock traded at EUR 25.2 per share at the end 2018 implying a market capitalization of USD 6,714 mil. Since the end of 2013, stock has appreciated by 30.8% implying an annual average growth of 5.52% In absolute terms, the value of the company ...
By Helgi Library - August 11, 2020
McKesson Europe's net debt stood at EUR 160 mil and accounted for 8.05% of equity at the end of 2018. The ratio is down 21.7 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 136% in 2000 and a low of...
By Helgi Library - August 11, 2020
McKesson Europe made a net profit of EUR -59.0 mil with revenues of EUR 21,177 mil in 2018, up by 80.3% and up by 0.412%, respectively, compared to the previous year. This translates into a net margin of -0.279%. Historically, between 1993 and 2018, ...
By Helgi Library - August 11, 2020
McKesson Europe made a net profit of EUR -59.0 mil in 2018, up 80.3% compared to the previous year. Historically, between 1993 and 2018, the company's net profit reached a high of EUR 435 mil in 1995 and a low of EUR -967 mil in 2016. The result implies a...
By Helgi Library - August 11, 2020
McKesson Europe stock traded at EUR 25.2 per share at the end 2018 translating into a market capitalization of USD 6,714 mil. Since the end of 2013, the stock has appreciated by 30.8% representing an annual average growth of 5.52%. At the end of 2018, th...
By Helgi Library - August 11, 2020
McKesson Europe invested a total of EUR 136 mil in 2018, up 16.2% compared to the previous year. Historically, between 2008 - 2018, the company's investments stood at a high of EUR 151 mil in 2015 and a low of EUR 88.0 mil in 2009. As...
McKesson Europe (formerly Celesio) is one of Europe's largest drug wholesalers, holding market-leading positions in several of the countries it serves. Its largest wholesale markets are France, Germany, and the UK. In addition to more than 130 wholesale distribution branches serving 65,000 pharmacies, McKesson Europe owns retail chains consisting of 2,200 pharmacies in Europe, including Norway, Italy, and the UK. The company, which was founded in 1835 and was acquired by North American pharmaceuticals distributor McKesson in 2014, has a presence in 14 countries.
McKesson Europe has been growing its sales by -1.05% a year on average in the last 5 years. EBITDA has fallen on average by 21.4% a year during that time to total of EUR 146 mil in 2018, or 0.689% of sales. That’s compared to 1.77% average margin seen in last five years.
The company netted EUR -59.0 mil in 2018 implying ROE of -3.02% and ROCE of -2.28%. Again, the average figures were -10.7% and -6.90%, respectively when looking at the previous 5 years.
McKesson Europe’s net debt amounted to EUR 160 mil at the end of 2018, or 8.05% of equity. When compared to EBITDA, net debt was 1.09x, down when compared to average of 2.10x seen in the last 5 years.
McKesson Europe stock traded at EUR 25.2 per share at the end of 2018 resulting in a market capitalization of USD 6,714 mil. Over the previous five years, stock price grew by 30.8% or 5.52% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 40.4x and price to earnings (PE) of -17.1x as of 2018.
Helgi Library 
